You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 4 Combinations of immune checkpoint inhibitors with fractionated radiotherapy or DNA damage response agents leads to improved anti-tumour responses and modulates the tumour immune microenvironment

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Biomarkers, Immune Monitoring and Novel Technologies
4 Combinations of immune checkpoint inhibitors with fractionated radiotherapy or DNA damage response agents leads to improved anti-tumour responses and modulates the tumour immune microenvironment

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023252018
Dec 20233109
Jan 20243605
Feb 20243204
Mar 20243006
Apr 20244007
May 20243203
Jun 202413407
Jul 20241403
Aug 202430011
Sep 20241601
Oct 202432010
Nov 202454013
Dec 2024604
Jan 20252606
Feb 2025006
Mar 2025007
Apr 2025002
May 2025006
Jun 2025003
Total7650131